1 – 10 of 167
- show: 10
- |
- sort: year (new to old)
- |
- Export
- 2023
- Previous and current efforts to develop a mucosal vaccine against periodontal disease : are we close yet? (2023) 30th European Veterinary Dental Forum, Book of Proceedings. p.191-193
- 2022
- Chitin immunomodulation stimulates anti-PD-1 therapy in an intraductal model for triple-negative breast cancer (2022)
- Molecular therapies and vaccines face the challenges of emerging infectious diseases (2022) MOLECULAR THERAPY. 30(5). p.1789-1790
- A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity (2022) MOLECULAR THERAPY. 30(9). p.2968-2983
- Choroid plexus-derived extracellular vesicles exhibit brain targeting characteristics (2022) BIOMATERIALS. 290.
- A lipid nanoparticle platform for mRNA delivery through repurposing of cationic amphiphilic drugs (2022) JOURNAL OF CONTROLLED RELEASE. 350. p.256-270
- Mucosal vaccination against periodontal disease : unexploited potential for veterinary and human oral medicine (2022) 36th Veterinary Dental Forum, Proceedings. p.21-26
- One cisplatin dose provides durable stimulation of anti-tumor immunity and alleviates anti-PD-1 resistance in an intraductal model for triple-negative breast cancer (2022) ONCOIMMUNOLOGY. 11(1).
- One cisplatin dose suffices to maintain anti-tumor immunity and enhances anti-PD-1 efficacy in an intraductal model for triple-negative breast cancer (2022) Recent insights into Immuno-Oncology, Abstracts.
- Regulatory guidelines and preclinical tools to study the biodistribution of RNA therapeutics (2022) ADVANCED DRUG DELIVERY REVIEWS. 184.